These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9179631)

  • 1. Citalopram as an adjuvant in schizophrenia: further evidence for a serotonergic dimension in schizophrenia.
    Taiminen TJ; Syvälahti E; Saarijärvi S; Niemi H; Lehto H; Ahola V; Salokangas RK
    Int Clin Psychopharmacol; 1997 Jan; 12(1):31-5. PubMed ID: 9179631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effects of antidepressants on negative symptoms in schizophrenia.
    Hinkelmann K; Yassouridis A; Kellner M; Jahn H; Wiedemann K; Raedler TJ
    J Clin Psychopharmacol; 2013 Oct; 33(5):686-90. PubMed ID: 23857309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: a randomized double-blind placebo-controlled trial.
    Iancu I; Tschernihovsky E; Bodner E; Piconne AS; Lowengrub K
    Psychiatry Res; 2010 Aug; 179(1):19-23. PubMed ID: 20472299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J; López-Carrilero R; Iniesta R; Roca M; Caballero M; Rodriguez-Jimenez R; Oliveira C; Bernardo M; Corripio I; Sindreu SD; González Piqueras JC; Felipe AE; Fernandez de Corres B; Ibáñez A; Huerta R;
    J Clin Psychiatry; 2014 Jun; 75(6):608-15. PubMed ID: 25004184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled study.
    Salokangas RK; Saarijärvi S; Taiminen T; Kallioniemi H; Lehto H; Niemi H; Tuominen J; Ahola V; Syvälahti E
    Acta Psychiatr Scand; 1996 Sep; 94(3):175-80. PubMed ID: 8891083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia.
    Zisook S; Montross L; Kasckow J; Mohamed S; Palmer BW; Patterson TL; Golshan S; Fellows I; Lehman D; Solorzano E
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):1005-14. PubMed ID: 18056819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.
    Kasckow J; Lanouette N; Patterson T; Fellows I; Golshan S; Solorzano E; Zisook S
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):183-90. PubMed ID: 19711335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia.
    Vartiainen H; Tiihonen J; Putkonen A; Koponen H; Virkkunen M; Hakola P; Lehto H
    Acta Psychiatr Scand; 1995 May; 91(5):348-51. PubMed ID: 7639092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
    Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S
    Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
    Mulholland C; Lynch G; King DJ; Cooper SJ
    J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression.
    Abel KM; O'Keane V; Murray RM; Cleare AJ
    Psychoneuroendocrinology; 1997 Oct; 22(7):539-48. PubMed ID: 9373887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ; Gergel I; Bose A
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study.
    Silver H; Shmugliakov N
    J Clin Psychopharmacol; 1998 Jun; 18(3):208-11. PubMed ID: 9617979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study.
    Jockers-Scherübl MC; Bauer A; Godemann F; Reischies FM; Selig F; Schlattmann P
    Int Clin Psychopharmacol; 2005 Jan; 20(1):27-31. PubMed ID: 15602113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents.
    Wagner KD; Robb AS; Findling RL; Jin J; Gutierrez MM; Heydorn WE
    Am J Psychiatry; 2004 Jun; 161(6):1079-83. PubMed ID: 15169696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citalopram in first episode schizophrenia: The DECIFER trial.
    Goff DC; Freudenreich O; Cather C; Holt D; Bello I; Diminich E; Tang Y; Ardekani BA; Worthington M; Zeng B; Wu R; Fan X; Li C; Troxel A; Wang J; Zhao J
    Schizophr Res; 2019 Jun; 208():331-337. PubMed ID: 30709746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.